HT = High Titers
ClontechÀÇ Lenti-X HT Packaging SystemÀº ±âÁ¸ÀÇ »ó¿ëÈ­µÈ packaging system°ú ºñ±³ ½Ã ¿ùµîÇÑ packaging ´É·Â°ú ¶Ù¾î³­ ¿ª°¡ (titer)¸¦ º¸ÀδÙ(Figure 1). 108 IFU/ml±îÁöÀÇ ¿ª°¡¸¦ ¾òÀ»¼ö ÀÖ¾î ³óÃàµÇÁö ¾ÊÀº ¹ÙÀÌ·¯½º »óû¾× 10¥ìl ¸¦ ÀÌ¿ëÇÏ¿© plate »óÀÇ ¸ñÀû ¼¼Æ÷ Àüü·Î ÇüÁúµµÀÔ ÇÒ ¼ö ÀÖ´Ù(Figure 2 & Figure 3). º» ½Ã½ºÅÛÀº ¸ñÀû À¯ÀüÀÚÀÇ copy ¼ö¸¦ Áõ°¡½ÃÄÑ ¹ßÇö ¼öÁØÀ» Áõ°¡½ÃÅ°±â À§ÇÏ¿© multiplicity of infection (MOI)À» Á¶ÀýÇÒ ¼ö ÀÖ°Ô ÇÑ´Ù.
½Ã³ÊÁö È¿°ú : ³ôÀº ¿ª°¡¸¦ À§ÇÑ ÇØ´ä
¾Æ·¡ÀÇ ±¸¼º¿ä¼Ò¸¦ 293T ¼¼Æ÷¿Í ÇÔ²² »ç¿ëÇϸé ClontechÀÇ Lenti-X System Vector »Ó¸¸ ¾Æ´Ï¶ó ´Ù¸¥ lentivirus vector¸¦ ÀÌ¿ëÇÒ ¶§µµ ÃÖ°í ¿ª°¡ÀÇ ¾ÈÀüÇÑ lentivirus¸¦ »ý»êÇÒ ¼ö ÀÖ´Ù.
2 Á¾ÀÇ Viral Pseudotypes ÀÌ¿ë
ÀϹÝÀûÀÎ Lenti-X HT Packaging SystemÀº ¸ðµç Á¾·ùÀÇ ¼¼Æ÷¿¡ Áï½Ã °¨¿°½Ãų ¼ö ÀÖ´Â VSV-G pseudotypeÀÇ ¹ÙÀÌ·¯½º¸¦ »ý»êÇÑ´Ù. Lenti-X HT Ecotropic Packaging SystemÀº MLV ecotropic envelope glycoprotein(gp70)À» °¡Áø pseudotypeÀÇ ¹ÙÀÌ·¯½º¸¦ »ý»êÇÑ´Ù. ÀÌ°ÍÀº mouse³ª rat ¼¼Æ÷¿¡ °íÈ¿À²·Î ÇüÁúµµÀÔ ½Ãų ¼ö ÀÖ´Ù.
Lenti-X 293T Packaging Cell Lines
Clontech¿¡¼­ ƯȭµÈ Lenti-X 293T Cell LineÀº ³ôÀº ÇüÁúµµÀÔÀÌ °¡´ÉÇÏ°í ¹ÙÀÌ·¯½º ´Ü¹éÁúÀ» °í¹ßÇöÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇØ ÁØ´Ù (1). ÀÌ·± Ư¼ºÀº Lenti-X HR Packaging SystemÀ» ÀÌ¿ëÇÏ¿© ÃÖ°íÀÇ lentivirus ¿ª°¡ (108 IFU/ml ÀÌ»ó)¸¦ »ý»êÇÒ ¼ö ÀÖ°Ô ÇÑ´Ù. Lenti-X HT Packaging System°ú Lenti-X vector¸¦ ÀÌ¿ëÇÏ¿© Lenti-X 293 Cell Line°ú ´Ù¸¥ 2 °³ÀÇ HEK 293 °è¿­ cell linesÀÇ ¹ÙÀÌ·¯½ºÀÇ »ý»ê·®À» ºñ±³ÇßÀ» ¶§ clontechÀÇ Lenti-X 293T ¼¼Æ÷°¡ 293FT ¼¼Æ÷º¸´Ù 6 ¹è, HEK293 cell linesº¸´Ù´Â 30 ¹è ÀÌ»ó ³ôÀº ¹ÙÀÌ·¯½º »ý»ê È¿À²À» º¸¿´´Ù.


Figure 1. The Lenti-X HT Packaging System. The lentiviral vector pLVXPuro and the Lenti-X HT Packaging Mix are cotransfected into Lenti-X 293T cells using the highly efficient Lentiphos HT transfection system. High titer supernatants are ready for use 48 hr after transfection.


Figure 2. High infectivity of supernatants produced by the Lenti-X HT Packaging System. The Lenti-X HT Packaging System and a Lenti-X vector (Panel A) and a competitor¡¯s packaging system and vector (Panel B) were each used to generate lentivirus for ZsGreen1 fluorescent protein expression. As little as 10¥ìl of culture supernatant from the Lenti-X HT Packaging System transduced the majority of a HeLa cell culture, whereas 10¥ìl of supernatant from the competitor¡¯s system transduced only a small percentage of the cells. Transduced cells were quantified by flow cytometry.


Figure 3. Lentiphos HT preserves 293T cell viability and allows production of more lentivirus. Virus production from Lenti-X 293T cells transfected with the Lenti-X HT Packaging System using a Lenti-X ZsGreen1 expression vector and Lentiphos HT transfection (Panels A & B), was compared to a competitor¡¯s packaging system and vector using their 293T cells and lipid-based transfection method (Panels C & D). After 48 hours, cell health and ZsGreen1 expression were visualized using phase contrast microscopy (Panels A & C) and fluorescence microscopy (Panels B & D). The Lenti-X culture produced a titer of 5.1 x 108 IFU/ml, whereas the competitor¡¯s system produced a titer that was 25-fold lower.


Figure 4. Transduction of neural progenitor cells by a Lenti-X lentivirus. ZsGreen1-expressing lentivirus was produced from the Lenti-X HT Packaging System and used to transduce normal human neural progenitor cells. A single transduced cell is shown under phase contrast microscopy (Panel A) and fluorescence microscopy (Panel B).

Components & Storage Conditions
°¢ Á¦Ç° ±¸¼º¹°°ú º¸°üÁ¶°ÇÀº Certificate of Analysis ¸¦ ÂüÁ¶ÇϽʽÿÀ.
References
1. Yin, D. X. et al. (1996) Anal. Biochem. 235:195-201.